Nasdaq:US$17.56 (+0.08) | HKEX:HK$27.38 (-0.22) | AIM:£2.48 (-0.06)
News & Presentations
Previous Article   |   Next Article
Presentations | 12 Oct 2023

Preclinical characterization of HMPL-415, a second-generation SHP2 inhibitor